About: Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 December 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu n'avientu de 2020 (ast) 2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 5ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް (dv) наукова стаття, опублікована 5 грудня 2020 (uk) scientific article published on 05 December 2020 (en)
publication date	wds:Q104076764-07186489-DB4D-457D-9F8A-BCD0A46DD4E0
publication date	2020-12-05 00:00:00Z (xsd:dateTime)
cites work	wds:Q104076764-0809EB46-F740-4994-86FB-AC23D6462E10 wds:Q104076764-29932C1D-BAB6-461D-B0FB-2788AF9E4758 wds:Q104076764-41230DEC-B492-45E0-8E44-996235260A01 wds:Q104076764-7C4E0947-2204-4F37-8414-0E501B7D7F04 wds:Q104076764-98E0AA94-CAC3-4080-9C92-7049E1B273A3 wds:Q104076764-9A0B8ACC-4479-4014-9D4F-401C2FBF5C8A wds:Q104076764-9E7CDE9B-4C8D-4AFF-AC98-7399258EB502 wds:Q104076764-C1B85517-B67D-432E-A641-4711BA321AB9 wds:Q104076764-D4C46074-4FAB-494A-B8DA-5C226CC934CA wds:Q104076764-E4BB4BC1-BECD-4C20-A862-1DCB35403CBD wds:Q104076764-E9F7CF14-127D-4C74-88BE-B4CD24915132 wds:Q104076764-F3C16913-DD79-4FDC-ADF4-ABADD9C7522D wds:Q104076764-F3DACA64-7725-4CE7-AD14-1709F8BD215E wds:Q104076764-FE7F079D-75ED-4869-B73D-093341A5B461
cites work	External validity of randomised controlled trials: "to whom do the results of this trial apply?". Differences between post-authorization adverse drug reactions of biopharmaceuticals and small molecules Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USA Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs Consistency in the safety labeling of bioequivalent medications Evaluation of FDA safety-related drug label changes in 2010. Number of patients studied prior to approval of new medicines: a database analysis Changes in clinical trial length Safety learning from drugs of the same class: room for improvement. Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports Different black box warning labeling for same-class drugs Potential Sunitinib-Induced Coronary Artery and Aortic Dissections.
author name string	wds:Q104076764-0D2FC955-14BE-42A8-BD32-11CD7587B2DC wds:Q104076764-7876BD5C-6C26-404E-8D05-D652D401C5D2 wds:Q104076764-7C11E3F5-BF5F-4447-89CD-EB2824E7913C wds:Q104076764-7EB39F12-61B4-4EA2-8539-526B850A9C6D wds:Q104076764-90E4F3B8-348A-4A8B-8220-84812C30F872 wds:Q104076764-A281D2EC-3794-423C-98ED-9A704ED735CA
author name string	Jarno Hoekman Toine C G Egberts Hubert G M Leufkens Helga Gardarsdottir Thijs J Giezen Lotte A Minnema
rdfs:label	Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors (dv) Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors (en) Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors (nl)
skos:prefLabel	Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors (dv) Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors (en) Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors (nl)
name	Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors (dv) Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors (en) Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors (nl)
title	wds:Q104076764-79154EB6-1CC8-4A12-B2F0-3655ED74ADA0
title	Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors (en)
instance of	wds:Q104076764-CA17CEC6-409A-40D5-9A11-79364560D966
instance of	scholarly article
PubMed ID	wds:Q104076764-ACAE9697-FD02-439B-AB11-0BB942E2AD9C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33278830
PubMed ID	33278830
published in	wds:Q104076764-448BF774-6AB7-4DF3-8AF6-EFAFADE64327
published in	Clinical Pharmacology & Therapeutics
DOI	wds:Q104076764-A79EB615-DA42-489B-85F3-2B93D62C0239
DOI	http://dx.doi.org/10.1002/CPT.2127
DOI	10.1002/CPT.2127
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q104076764

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software